November 16, 2021
Via: European Pharmaceutical ReviewThe US Food and Drug Administration (FDA) has approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red blood cells. Besremi is the first FDA-approved medication for polycythemia vera that […]
July 11, 2024
July 11, 2024
July 19, 2024